Loading...
Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients
PURPOSE: The aim of this study was to evaluate whether pretreatment analysis of selected molecular markers can be used for the prediction of disease-free survival (DFS)/overall survival (OS) of capecitabine adjuvant monotherapy in colon cancer patients. PATIENTS AND METHODS: A total of 126 patients...
Na minha lista:
| Udgivet i: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6219100/ https://ncbi.nlm.nih.gov/pubmed/30464574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S172467 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|